Latest Impairment News

Sequoia Financial Group has agreed to sell its financial planning arm InterPrac to Conquest Investment Partners for $50,000, following a strategic review that exposed significant challenges and asset write-downs.

Novo Resources Corp. reported a net loss of CAD 22.4 million for 2025, slightly improving from the previous year, while securing a $5.9 million capital raise to support ongoing exploration and operations.

Turners Automotive Group has raised its net profit guidance for FY26 to $63 million, driven by robust vehicle sales and record finance lending, despite a goodwill write-down in its EC Credit division.

Image Resources NL is set to record significant non-cash impairments totalling around A$61 million in its 2025 financial results, reflecting challenges from weaker mineral sands prices and a stronger Australian dollar.

Atlas Pearls Ltd has disclosed a significant 27% revenue decline and a net loss for the half year ended December 2025, attributing the results to weaker auction outcomes and one-off accounting impacts. The company affirms timely disclosure and compliance with ASX rules amid market sensitivity.

Novo Resources has completed the first tranche of a capital raising, securing A$6.2 million, while announcing significant valuation impairments ahead of its 2025 financial report.

Bapcor Limited has initiated a fully underwritten $200 million equity raising at $0.60 per share, aiming to reduce debt and support a strategic turnaround under new leadership. The retail entitlement offer opened on 5 March and closes on 19 March 2026.

MCS Services Limited reported a 32% revenue decline for the half-year ending December 2025, alongside improved EBITDA and no significant impairments. The company is moving forward with a proposed sale of its Highways Traffic business, though an auditor’s going concern warning casts a shadow over its near-term outlook.

Peak Processing Limited reported a sharp 47.7% revenue drop and a 257.7% increase in losses for H1 2026, alongside a significant asset impairment and ongoing going concern concerns.

Vmoto Limited reported an 18% revenue decline to $46.8 million and a $9.9 million net loss in FY25, while accelerating its transformation into a full-stack electric mobility solutions provider with new global partnerships and product innovations.

Argent BioPharma reported a significantly reduced half-year loss of A$2.9 million, progressing a strategic acquisition to bolster its CannEpil drug pipeline and securing up to A$11 million in new funding.

TerraCom Limited reported a significant half-year loss amid falling coal prices and production challenges, completing a $56 million capital raise to strengthen its financial position.